Cellular Health Screening Market Share

North American Market Forecasts

The North America region is set to hold 33% share of the global cellular health screening market by 2037. The growth of this market can be attributed on the back of increasing awareness about personalized medicines, growing government initiatives supporting preventive healthcare, and growing adoption of new technologies. Besides this robust expansion of healthcare infrastructure in the North America region is estimated to boost the market growth of cellular health screening in this region during the projection period. In June 2021, Grail launched a unique blood test capable of detecting the presence of multiple cancers using the Galleri diagnostic method. This test is intended to screen people at high risk of cancer, such as adults over 50 years old. Such initiatives by major players in the market are leading to increased adoption of cellular health screening in the region, thereby driving market growth.

Asia Pacific Market Statistics

The cellular health screening market in the Asia Pacific is estimated to hold a substantial growth during the forecast timeframe. The increase in the number of people, which is contributing to a large patient pool and creating an infrastructure for health care due to increased economic activity, accounts for this. The key drivers for growth in the Asia Pacific region include improved adoption of tests and awareness by adults about their health. Regional growth is also supported by higher research on telomere senescence, as well as public policies aimed at preventing diseases.